✦ LIBER ✦

Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

✍ Scribed by Tsimberidou, Apostolia M.; Wierda, William G.; Wen, Sijin; Plunkett, William; O'Brien, Susan; Kipps, Thomas J.; Jones, Jeffrey A.; Badoux, Xavier; Kantarjian, Hagop; Keating, Michael J.

Book ID: 122863248
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 413 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.03.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I Study of Fludarabine, Cytarabi

A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

✍ Tsimberidou, Apostolia Maria; Keating, Michael J.; Jabbour, Elias J.; Ravandi-Ka 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 208 KB

Phase II Study of Lenalidomide and Ritux

Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

✍ Badoux, X. C.; Keating, M. J.; Wen, S.; Wierda, W. G.; O'Brien, S. M.; Faderl, S 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 137 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB